DME/Retina Edition: Top Headlines for Week of May 6, 2024
Manage episode 417324168 series 3560281
In this edition, FDA accepts new drug application for Eluminex, most mentors in vitreoretinal subspecialty are men and more. Read the full coverage here:
FDA accepts investigational new drug application for Eluminex DME treatment
Most mentors in vitreoretinal subspecialty are men
Carotid artery stenosis linked to retinal changes in patients with diabetic retinopathy
AI-assisted technology makes retinal imaging 100 times faster, with greater contrast
FDA clears fully autonomous AI for portable diabetic retinopathy screening
References:
Das V, et al. Commun Med. 2024;doi:10.1038/s43856-024-00483-1.
Lee CY, et al. BMC Ophthalmol. 2024;doi:10.1186/s12886-024-03391-z.
Shah SM, et al. Demographics and productivity trends among academically affiliated female vitreoretinal specialists in the United States. Presented at: Real World Ophthalmology; April 27, 2024 (virtual meeting).
118 episoder